MASH
-
Novo Nordisk to Acquire Akero Therapeutics for $5.2B, Targeting Breakthrough Liver Drug
Novo Nordisk has announced its acquisition of Akero Therapeutics for up to $5.2 billion, aiming to secure a promising liver disease treatment and strengthen its position in metabolic and cardiometabolic therapies.
-
Loretta Swit, Beloved ‘M*A*S*H’ Star, Dies at 87
Loretta Swit, Emmy-winning actress best known for her role as Margaret ‘Hot Lips’ Houlihan on ‘M*A*S*H,’ passed away at 87 in New York City.
-
Semaglutide Shows Promise in Treating Liver Disease MASH
A landmark phase 3 trial reveals semaglutide’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease affecting millions globally.
-
Wegovy Shows Promise in Treating Advanced Liver Disease, Study Finds
Clinical trials reveal Wegovy’s potential to treat metabolic dysfunction-associated steatohepatitis (MASH), reducing liver inflammation and fibrosis in patients.